Morpholine → 3-Benzenesulphonyl-5-methyl-2-methylsulphanyl-7-morpholin-4-yl-pyrazolo[1,5-a]pyrimidine
反応式
[NH:1]1[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.[C:7]1([S:13]([C:16]2[C:17]([S:27][CH3:28])=[N:18][N:19]3[C:24](Cl)=[CH:23][C:22]([CH3:26])=[N:21][C:20]=23)(=[O:15])=[O:14])[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=1>CN(C=O)C>[C:7]1([S:13]([C:16]2[C:17]([S:27][CH3:28])=[N:18][N:19]3[C:24]([N:1]4[CH2:6][CH2:5][O:4][CH2:3][CH2:2]4)=[CH:23][C:22]([CH3:26])=[N:21][C:20]=23)(=[O:15])=[O:14])[CH:8]=[CH:9][CH:10]=[CH:11][CH:12]=1参加物
4
実験手順
0.20 g (2.2 mmol) of morpholine was added to a solution of 0.25 g (0.85 mmol) of 3-benzenesulphonyl-7-chloro-5-methyl-2-methylsulphanyl-pyrazolo[1,5-a]pyrimidine in 10 l of DMF and stirred at 60° for 1 hr. The reaction solution was cooled to RT and evaporated in a high vacuum. The residue was partitioned between 2N NaOH and CH2Cl2. The aqueous phase was extracted three times with CH2Cl2, and the combined organic phases were dried (MgSO4), filtered and evaporated. Subsequent chromatography (SiO2, CH2Cl2/MeOH 25:1) and crystallization from EtOH yielded 0.20 g (70%) of 3-benzenesulphonyl-5-methyl-2-methylsulphanyl-7-morpholin-4-yl-pyrazolo[1,5-a]pyrimidine as colorless crystals, m.p. 206-208°.
後処理
- customevaporated in a high vacuum
- customThe residue was partitioned between 2N NaOH and CH2Cl2
- extractionThe aqueous phase was extracted three times with CH2Cl2
- dry with materialthe combined organic phases were dried (MgSO4)
- filtrationfiltered
- customevaporated
- customSubsequent chromatography (SiO2, CH2Cl2/MeOH 25:1) and crystallization from EtOH
出典と根拠
- ORDレコード
- ord-7ee9b931c96e4d47a0aae577ece9f3fa
- 出典データセット
- uspto-grants-2001_02
- 特許番号
- US06194410B1
反応ノート
読み込み中…